Overview

A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions

Status:
Completed
Trial end date:
2017-08-15
Target enrollment:
Participant gender:
Summary
This is an open-label, three part study to evaluate the effect of BCX7353 on drug transporters as well as the effect of an inhibitor of drug transport on BCX7353.
Phase:
Phase 1
Details
Lead Sponsor:
BioCryst Pharmaceuticals
Treatments:
Berotralstat
Cyclosporine
Cyclosporins
Digoxin
Rosuvastatin Calcium